Avanos Medical Inc
NYSE:AVNS
Avanos Medical Inc
NYSE:AVNS
Price:
19.58 USD
0.56%
Market Closed
Updated:
May 11, 2024
EV/OCF
Enterprise Value to OCF
Enterprise Value to OCF
30.1
Current
19.4
Median
15.4
Industry
Higher
than median
Higher
than industry value
Enterprise Value to Operating Cash Flow (EV/OCF) ratio is a valuation multiple that measures the value of a company, debt included, to the operating cash flow it generates.
EV/OCF
=30.1
Enterprise Value
/
975.8m
Operating Cash Flow
32.4m
All Countries
| Market Cap | EV/OCF | ||||
|---|---|---|---|---|---|
| US |
|
Avanos Medical Inc
NYSE:AVNS
|
904.1m USD | 30.1 | |
| JP |
|
Hoya Corp
TSE:7741
|
6.3T JPY | 28.8 | |
| CH |
|
Alcon AG
SIX:ALC
|
36.3B CHF | 31.6 | |
| DK |
|
Coloplast A/S
CSE:COLO B
|
190B DKK | 37.2 | |
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
20.4B USD | 24.9 | |
| US |
|
Cooper Companies Inc
NYSE:COO
|
18.8B USD | 38.1 | |
| KR |
H
|
HLB Inc
KOSDAQ:028300
|
13.1T KRW | -116.8 | |
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
61.2B CNY | 38.5 | |
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
5.4B GBP | 343.3 | |
| US |
|
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
5.8B USD | 17.1 | |
| CA |
B
|
Bausch + Lomb Corp
NYSE:BLCO
|
5.4B USD | 120.7 |
EV/OCF Forward Multiples
Forward EV/OCF multiple is a version of the EV/OCF ratio that uses forecasted operating cash flow for the EV/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
EV/OCF
N/A
2-Years Forward
EV/OCF
N/A
3-Years Forward
EV/OCF
N/A
You don't have any saved screeners yet
